PF-06473871
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-06473871, covering 2014-09-26 to 2015-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery [Phase 2]